Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Verdun

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2016
Epstein-Barr virus-positive follicular lymphomaNicholas Mackrides, German Campuzano-Zuluaga, Yvan Maque-Acosta, et al.
Blood|November 26, 2015
Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphomaNitin K Agarwal, Chae H Kim, Kranthi Kunkalla, et al.
Blood Advances|August 1, 2019
Interplay between HGAL and Grb2 proteins regulates B-cell receptor signalingXiaoyu Jiang, Xiaoqing Lu, Yu Zhang, et al.
Nature Communications|March 30, 2018
A licensing step links AID to transcription elongation for mutagenesis in B cellsStephen P Methot, Ludivine C Litzler, Poorani Ganesh Subramani, et al.
Journal of the Neurological Sciences|March 4, 1999
Autoimmune events during interferon beta-1b treatment for multiple sclerosisL Durelli, B Ferrero, A Oggero, et al.
NAR Cancer|July 28, 2021
Erratum: The uracil-DNA glycosylase UNG protects the fitness of normal and cancer B cells expressing AIDShiva Safavi, Ariane Larouche, Astrid Zahn, et al.
NAR Cancer|February 8, 2021
The uracil-DNA glycosylase UNG protects the fitness of normal and cancer B cells expressing AIDShiva Safavi, Ariane Larouche, Astrid Zahn, et al.
Research Square|May 10, 2023
PRAME induces genomic instability in uveal melanomaStefan Kurtenbach, Margaret I Sanchez, Jeffim Kuznetsoff, et al.
Cancer Cell|August 27, 2019
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCLSalma Parvin, Ariel Ramirez-Labrada, Shlomzion Aumann, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2016
Epstein-Barr virus-positive follicular lymphomaNicholas Mackrides, German Campuzano-Zuluaga, Yvan Maque-Acosta, et al.
Blood|November 26, 2015
Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphomaNitin K Agarwal, Chae H Kim, Kranthi Kunkalla, et al.
Blood Advances|August 1, 2019
Interplay between HGAL and Grb2 proteins regulates B-cell receptor signalingXiaoyu Jiang, Xiaoqing Lu, Yu Zhang, et al.
Nature Communications|March 30, 2018
A licensing step links AID to transcription elongation for mutagenesis in B cellsStephen P Methot, Ludivine C Litzler, Poorani Ganesh Subramani, et al.
Journal of the Neurological Sciences|March 4, 1999
Autoimmune events during interferon beta-1b treatment for multiple sclerosisL Durelli, B Ferrero, A Oggero, et al.
NAR Cancer|July 28, 2021
Erratum: The uracil-DNA glycosylase UNG protects the fitness of normal and cancer B cells expressing AIDShiva Safavi, Ariane Larouche, Astrid Zahn, et al.
NAR Cancer|February 8, 2021
The uracil-DNA glycosylase UNG protects the fitness of normal and cancer B cells expressing AIDShiva Safavi, Ariane Larouche, Astrid Zahn, et al.
Research Square|May 10, 2023
PRAME induces genomic instability in uveal melanomaStefan Kurtenbach, Margaret I Sanchez, Jeffim Kuznetsoff, et al.
Cancer Cell|August 27, 2019
LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCLSalma Parvin, Ariel Ramirez-Labrada, Shlomzion Aumann, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinomaLucas D Caeiro, Yuichiro Nakata, Rodrigo L Borges, et al.
Pageof 6